Abstract
The facilities for neonatal screening, early diagnosis, and effective treatment of isovaleric acidaemia (IVA) have improved greatly over the past decades. Accordingly, IVA patients reach adolescence and may consider having children. The maintenance of a stable metabolic condition is a challenge to both the patients and their multidisciplinary team of care providers. This report presents three women with IVA during their five single or twin pregnancies, whose clinical condition were monitored with contrasting approaches. Metabolic profiles were determined and compared in these pregnancies. In one case, two pregnancies were strictly managed and monitored by measuring plasma acylcarnitine and amino acid profiles, together with adjustment of the diet and/or supplementation of l-carnitine and/or glycine. In addition, complications were prevented by intravenous glucose and l-carnitine during labor and postpartum. In two other cases, the metabolic condition of patients was less frequently monitored and additional treatment with intravenous l-carnitine and intravenous glucose/dextrose was only prescribed during periods of hyperemesis gravidarum. With respect to the differences in management and monitoring of maternal IVA all pregnancies were without complications for mother and child. Despite the favorable outcome in uncontrolled pregnancies in IVA, careful monitoring and management during pregnancy is helpful to prevent life-threatening conditions like metabolic decompensation.
Competing interests: None declared.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- IVA:
-
Isovaleric acidaemia
- IVD:
-
Isovaleryl-CoA dehydrogenase
References
Blau N, Duran M, Gibson KM (2008) Laboratory guide of the methods in biochemical genetics. Springer, Berlin
Cleal JK, Brownbill P, Godfrey KM, Jackson JM, Jackson AA, Sibley CP, Hanson MA, Lewis RM (2007) Modification of fetal plasma amino acid composition by placental amino acid exchangers in vitro. J Physiol 582:871–882
Doberenz J, Birkenfeld C, Kluge H, Eder K (2006) Effects of l-carnitine supplementation in pregnant sows on plasma concentrations of insulin-like growth factors, various hormones and metabolites and chorion characteristics. J Anim Physiol Anim Nutr (Berl) 90:487–499
El-Hattab AW, Li FY, Shen J, Powell BR, Bawle EV, Adams DJ, Wahl E, Kobori JA, Graham B, Scaglia F, Wong LJ (2010) Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet Med 12:19–24
Fries MH, Rinaldo P, Schmidt-Sommerfeld E, Jurecki E, Packman S (1996) Isovaleric acidemia: response to a leucine load after three weeks of supplementation with glycine, l-carnitine, and combined glycine-carnitine therapy. J Pediatr 129:449–452
Ghadimi H, Pecora P (1964) Free amino acids of cord plasma as compared with maternal plasma during pregnancy. Pediatrics 33:500–506
Harper P, Elwin CE, Cederblad G (1988) Pharmacokinetics of bolus intravenous and oral doses of l-carnitine in healthy subjects. Eur J Clin Pharmacol 35:69–75
Lee PJ (2006) Pregnancy issues in inherited metabolic disorders. J Inherit Metab Dis 29:311–316
Martin-Hernandez E, Lee PJ, Micciche A, Grunewald S, Lachmann RH (2009) Long-term needs of adult patients with organic acidaemias: outcome and prognostic factors. J Inherit Metab Dis 32:523–533
Oey NA, van Vlies N, Wijburg FA, Wanders RJ, Attie-Bitach T, Vaz FM (2006) l-carnitine is synthesized in the human fetal-placental unit: potential roles in placental and fetal metabolism. Placenta 27:841–846
Preece MA, Green A (2002) Pregnancy and inherited metabolic disorders: maternal and fetal complications. Ann Clin Biochem 39:444–455
Rubio-Gozalbo ME, Gubbels CS, Bakker JA, Menheere PP, Wodzig WK, Land JA (2010) Gonadal function in male and female patients with classic galactosemia. Hum Reprod Update 16:177–188
Shih VE, Aubry RH, DeGrande G, Gursky SF, Tanaka K (1984) Maternal isovaleric acidemia. J Pediatr 105:77–78
Spinty S, Rogozinski H, Lealman GT, Wraith JE (2002) Second case of a successful pregnancy in maternal isovaleric acidaemia. J Inherit Metab Dis 25:697–698
Talian GC, Komlosi K, Decsi T, Koletzko B, Melegh B (2007) Determination of carnitine ester patterns during the second half of pregnancy, at delivery, and in neonatal cord blood by tandem mass spectrometry: complex and dynamic involvement of carnitine in the intermediary metabolism. Pediatr Res 62:88–92
van Spronsen FJ, Molendijk H, Erwich JJ, Smit GP (2003) Inherited metabolic diseases and pregnancy: consequences for mother and child. Ned Tijdschr Geneeskd 147:235–240
Vockley J, Ensenauer R (2006) Isovaleric acidemia: new aspects of genetic and phenotypic heterogeneity. Am J Med Genet C Semin Med Genet 142C:95–103
Walter JH (2000) Inborn errors of metabolism and pregnancy. J Inherit Metab Dis 23:229–236
Winter SC, Linn LS, Helton E (1995) Plasma carnitine concentrations in pregnancy, cord blood, and neonates and children. Clin Chim Acta 243:87–93
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Jerry Vockley.
Electronic Supplementary material
Appendices
Synopsis
Managing a well-controlled metabolic condition of the patient with IVA is the main goal in general and should be especially so during pregnancy.
Consent
Written informed consent was obtained from the patient for publication of this case report.
Author’s Contribution
All authors have contributed to the work presented in this manuscript.
Rights and permissions
Copyright information
© 2011 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Habets, D.D.J. et al. (2011). Biochemical Monitoring and Management During Pregnancy in Patients with Isovaleric Acidaemia is Helpful to Prevent Metabolic Decompensation. In: JIMD Reports - Case and Research Reports, 2011/3. JIMD Reports, vol 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2011_66
Download citation
DOI: https://doi.org/10.1007/8904_2011_66
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-24935-8
Online ISBN: 978-3-642-24936-5
eBook Packages: MedicineMedicine (R0)